类风湿关节炎风险人群肠道微生物组动态:横断面与纵向观察研究
研究纳入124例抗CCP抗体阳性伴新发肌肉骨骼症状但无临床滑膜炎的类风湿关节炎(RA)风险个体,基线采样30例进展为RA,另对19例纵向随访15个月。进展者基线普雷沃菌科丰度与非进展者存在显著差异,且RA发病前10个月出现肠道微生物组不稳定。
要点
- 抗CCP抗体阳性风险人群中,进展者与非进展者基线普雷沃菌科丰度存在显著差异,差异取决于内在RA风险因素和进展时间。
- 纵向采样显示进展者在RA发病前10个月出现肠道微生物组不稳定,非进展者无此现象。
- 关节炎发展过程中肠道微生物组结构变化与氨基酸代谢增加相关。
核心结论
- 普雷沃菌科丰度报道矛盾可能源于在动态疾病谱中对异质性人群采样,某些普雷沃菌科菌株/分支可能参与RA发生和/或进展。
- RA肠道微生物组变化可能出现在向临床关节炎过渡时,作为晚期表现,尚不清楚是原发还是继发现象。
研究设计与样本
- 横断面与纵向观察研究,RA风险定义为抗CCP抗体阳性伴新发肌肉骨骼症状但无临床滑膜炎。
- 基线采样124例(30例进展为RA),纵向采样19例(5例进展为RA),随访15个月共5个时间点。
- 采用16S rRNA扩增子测序分析肠道微生物组分类变化,并在49份样本中以鸟枪法宏基因组DNA测序确认。
主要发现
- 基线时抗CCP抗体阳性风险进展者与非进展者相比普雷沃菌科丰度存在显著差异,取决于内在RA风险因素和进展时间。
- 纵向采样显示进展者在RA发病前10个月出现肠道微生物组不稳定,非进展者无此现象。
- 关节炎发展过程中肠道微生物组结构变化与氨基酸代谢增加相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文指出肠道微生物组变化是原发现象还是继发现象尚不清楚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: This work aimed to resolve the conflicting reports on Prevotellaceae abundance in the development of rheumatoid arthritis (RA) and to observe structural, functional and temporal changes in the gut microbiome in RA progressors versus non-progressors. METHODS: Individuals at risk of RA were defined by the presence of anticyclic citrullinated protein (anti-CCP) antibodies and new musculoskeletal symptoms without clinical synovitis. Baseline sampling included 124 participants (30 progressed to RA), with longitudinal sampling of 19 participants (5 progressed to RA) over 15 months at five timepoints. Gut microbiome taxonomic alterations were investigated using 16S rRNA amplicon sequencing and confirmed with shotgun metagenomic DNA sequencing on 49 samples. RESULTS: At baseline, CCP+ at risk progressors showed significant differences in Prevotellaceae abundance compared with non-progressors, contingent on intrinsic RA risk factors and time to progression. Longitudinal sampling revealed gut microbiome instability in progressors 10 months before RA onset, a phenomenon absent in non-progressors. This may indicate a late microbial shift before RA onset, with Prevotellaceae contributing but not dominating these changes. Structural changes in the gut microbiome during arthritis development were associated with increased amino acid metabolism. CONCLUSION: These data suggest conflicting reports on Prevotellaceae overabundance are likely due to sampling within a heterogeneous population along a dynamic disease spectrum, with certain Prevotellaceae strains/clades possibly contributing to the establishment and/or progression of RA. Gut microbiome changes in RA may appear at the transition to clinical arthritis as a late manifestation, and it remains unclear whether they represent a primary or secondary phenomenon.
引用
- Rooney CM, Jeffery IB, Mankia K, et al. Dynamics of the gut microbiome in individuals at risk of rheumatoid arthritis: a cross-sectional and longitudinal observational study. Ann Rheum Dis. 2024. PMID: 39515835. doi:10.1136/ard-2024-226362
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。